Recent years have witnessed an increased prevalence of intrinsic and acquired beta-lactamase-producing bacteria, severely limiting human and veterinary medicine therapeutic options. The present study aimed to design specific oligonucleotides for rapid PCR detection of the cephalosporinase-encoding gene blaEC (BlaEC family class C beta-lactamase). A total of three primers were designed to detect 2281 variants of the blaEC gene and two sets of primer pairs were also tested against DNA from 11 strains. The study indicates that the proposed primers should be able to detect 100% of all described blaEC genes in different bacterial strains and monitor their spread. After comparing the amino acid sequences, a phylogenetic tree was created based on the presence of conserved amino acids and homologous motifs. More than 24 760 mutations in BlaEC enzymes have been identified. The mutations involving 371 amino acid positions and these hotspots can change the structure and activity of the monitored enzymes. We predicted several BlaEC enzymes with a broadened substrate activity against higher-generation cephalosporins.

Department of Biotechnology Faculty of Science Palacky University Olomouc 17 listopadu 1192 12 779 00 Olomouc Czechia

Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Hnevotinska 3 779 00 Olomouc Czechia

Zobrazit více v PubMed

Bonnin RA, Jousset AB, Emeraud Cet al. . Genetic diversity, biochemical properties, and detection methods of minor carbapenemases in Enterobacterales. Front Med. 2020;7:616490. PubMed PMC

Bush K. The ABCD’s of beta-lactamase nomenclature. J Infect Chemother. 2013;19:549–59. PubMed

Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54:969–76. PubMed PMC

Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother. 2001;45:3595–8. PubMed PMC

Doi Y, Wachino J, Ishiguro Met al. . Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob Agents Chemother. 2004;48:2652–8. PubMed PMC

Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. PubMed PMC

Gray VE, Hause RJ, Fowler DM. Analysis of large-scale mutagenesis data to assess the impact of single amino acid substitutions. Genetics. 2017;207:53–61. PubMed PMC

Guindon S, Dufayard JF, Lefort Vet al. . New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21. PubMed

Hanson ND, Sanders CC. Regulation of inducible AmpC beta-lactamase expression among enterobacteriaceae. CPD. 1999;5:881–94. PubMed

Harris PN, Ferguson JK. Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. Int J Antimicrob Agents. 2012;40:297–305. PubMed

Jacobs C, Joris B, Jamin Met al. . AmpD, essential for both β-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol Microbiol. 1995;15:553–9. PubMed

Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22:161–82. PubMed PMC

Jeon JH, Hong MK, Lee JHet al. . Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum beta-lactamase isolated from Acinetobacter baumannii. Acta Crystallogr D Biol Crystallogr. 2014;70:2924–36. PubMed

Kearse M, Moir R, Wilson Aet al. . Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28:1647–9. PubMed PMC

Liu S, Huang N, Zhou Cet al. . Molecular mechanisms and epidemiology of carbapenem-resistant Enterobacter cloacae complex isolated from Chinese patients during 2004–2018. IDR. 2021;14:3647–58. PubMed PMC

Mac Aogain M, Rogers TR, Crowley B. Identification of emergent bla CMY-2 -carrying Proteus mirabilis lineages by whole-genome sequencing. New Microbes New Infect. 2016;9:58–62. PubMed PMC

Mack AR, Barnes MD, Taracila MAet al. . A standard numbering scheme for class C beta-lLactamases. Antimicrob Agents Chemother. 2020;64. 10.1128/AAC.01841-19. PubMed DOI PMC

Mammeri H, Poirel L, Fortineau Net al. . Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob Agents Chemother. 2006;50:2573–6. PubMed PMC

Mlynarcik P, Chalachanova A, Vagnerova Iet al. . PCR detection of oxacillinases in bacteria. Microb Drug Resist. 2020;26. 10.1089/mdr.2019.0330. PubMed DOI

Mlynarcik P, Dolejska M, Vagnerova Iet al. . Detection of clinically important beta-lactamases by using PCR. FEMS Microbiol Lett. 2021a;368. 10.1093/femsle/fnab068. PubMed DOI

Mlynarcik P, Chudobova H, Zdarska Vet al. . In silico analysis of extended-spectrum beta-lactamases in bacteria. Antibiotics. 2021b;10:812. PubMed PMC

Naas T, Oueslati S, Bonnin RAet al. . Beta-lactamase database (BLDB)—structure and function. J Enzyme Inhib Med Chem. 2017;32:917–9. PubMed PMC

Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1990;34:2200–9. PubMed PMC

Suh B, Bae IK, Kim Jet al. . Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss. Antimicrob Agents Chemother. 2010;54:5057–61. PubMed PMC

Tomas M, Doumith M, Warner Met al. . Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 2010;54:2219–24. PubMed PMC

Vakulenko SB, Golemi D, Geryk Bet al. . Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime. Antimicrob Agents Chemother. 2002;46:1966–70. PubMed PMC

Weber DA, Sanders CC. Diverse potential of beta-lactamase inhibitors to induce class I enzymes. Antimicrob Agents Chemother. 1990;34:156–8. PubMed PMC